Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 305 publications
Successful Treatment of Relapsed Transformed Aggressive B-Cell Lymphoma After Autologous Hematopoietic Stem Cell Transplantation With Polatuzumab Vedotin Combined With Bendamustine and Rituximab Followed by Nonmyeloablative Related HLA-Identical Stem Cell Transplantation.
Journal: American journal of therapeutics
Published: December 08, 2025
Hereditary Neuropathy with Liability to Pressure Palsies Unmasked by Polatuzumab Vedotin-containing Chemotherapy.
Journal: Internal medicine (Tokyo, Japan)
Published: November 19, 2025
Diffuse large B-cell lymphoma: what clinical progress have we seen in the last 5 years?
Journal: Expert opinion on investigational drugs
Published: November 08, 2025
Safety profiles in elderly patients with DLBCL on first-line Pola-R-CHP: a claims database study in Japan.
Journal: Leukemia & lymphoma
Published: November 03, 2025
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 20, 2025
First-line treatment with polatuzumab vedotin improves efficacy and survival in newly diagnosed patients with advanced diffuse large B-cell lymphoma: a multicentre retrospective analysis.
Journal: Annals of medicine
Published: October 10, 2025
Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2025
SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 25, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 24, 2025
Efficacy of Pola-R-CHP and Autologous Stem Cell Transplantation in Untreated Burkitt Lymphoma: A Case Report.
Journal: The American journal of case reports
Published: September 24, 2025
Real-World Comparative Analysis of Polatuzumab Vedotin-Based Pola-R-CHP Versus Standard R-CHOP in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort Study.
Journal: Oncology
Published: September 10, 2025
Polatuzumab vedotin in the treatment of relapsed or refractory DLBCL: a case report
Journal: Recenti progressi in medicina
Published: August 28, 2025
Last Updated: 01/07/2026